- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Sevelamer – November 2017
Sevelamer: Powder for oral liquid 2.4 g (as carbonate); Renvela®
Last updated
2 March 2018